Interreg EMR funded project “The Impact of COVID-19 on the Meuse-Rhine Euroregion (EMR)” (“euPrevent COVID-19”) has released its first results. This project consists of two rounds of blood sample tests and analyses of the anti-body in relation to the national COVID response measures in the EMR countries. The first round test was completed in October, and the result of the first analysis was released in a factsheet which gives an overview of the progress of the project and the highlights the major findings.